International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
The Korean Journal of Internal Medicine
Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study | Haematologica
Diffuse large B-cell lymphoma - Wikipedia
Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role? | Haematologica
B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study - eBioMedicine
Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy | NEJM
Type 2 diabetes mellitus compromises the survival of diffuse large B-cell lymphoma patients treated with (R)-CHOP – the PLRG report | Scientific Reports
Progression-free survival and overall survival rates of DLBCL patients,... | Download Scientific Diagram
Preventative Treatment Improves Survival in Localized Primary DLBCL
Evolution of therapy for limited stage diffuse large B-cell lymphoma | Blood Cancer Journal
Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989–2018 | Blood Cancer Journal
Diffuse large B cell lymphoma: Outlook, stages, treatment
Overall survival (OS) in all 75 patients with diffuse large B-cell... | Download Scientific Diagram
Diffuse large B-cell lymphoma symptoms, diagnosis and treatment - YouTube
The overall survival of in diffuse large B-cell lymphoma (DLBCL)... | Download Scientific Diagram
Primary extra‑nodal diffuse large B‑cell lymphoma: A prognostic analysis of 141 patients
Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden | Blood Cancer Journal
A: Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System - The ASCO Post
Real-World Evidence of Axicabtagene Ciloleucel for the Treatment of Large B Cell Lymphoma in the United States - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular
Ibrutinib improves diffuse large B-cell lymphoma survival - NCI
Overall survival of patients with diffuse large B-cell lymphoma after... | Download Scientific Diagram
Diffuse Large B-cell Lymphoma: Symptoms, Treatment and Prognosis: 9781634844024: Medicine & Health Science Books @ Amazon.com
2-year survival rates of acute lymphoblastic leukemia, diffuse large... | Download Scientific Diagram
